Found 118 clinical trials
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
- 346 views
- 25 Mar, 2021
- 1 location
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
)patients with vasculitis or glomerulonephritis. Approximately 1500 participants will be randomised to active treatment or placebo, stratified by PROTECT sub-population, age and participating sites
- 0 views
- 11 May, 2021
- 1 location
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
vasculitis patients with relapses. Nevertheless, it was an indirect estimation of treatment effect because of the absence of dedicated randomized trial. This meta-analysis concluded that combined longer
- 0 views
- 23 Jan, 2021
- 58 locations
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
investigate the role for vasculitis of KD or regression of dilatation.
- 25 views
- 25 Jan, 2021
- 1 location
Study of T Lymphocytes in Patients With Horton Disease
Giant-cell arteritis (GCA) is the most frequent vasculitis after 50 years. Corticosteroid therapy is the reference treatment for GCA. This treatment is highly effective but must be maintained
- 1 views
- 23 Jan, 2021
- 1 location
Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
connective tissue disorder [UCTD], Sjogren, antiphospholipid syndrome - APS, vasculitides, systemic lupus erythematosus [SLE], polymyositis, Hashimoto, multiple sclerosis, primary biliary
- 11 views
- 07 Nov, 2020
- 1 location
Clinical Study on Strategy for Refractory Henoch-Sch nlein Purpura
IgA vasculitis is relatively common in children,especially in Asian countries. Abdominal manifestation could be severe, including bleeding, pancreatitis,appendicitis and intestinal
- 0 views
- 26 Jan, 2021
- 3 locations
Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
Giant cell arteritis (GCA) is the most common form of vasculitis after age 50. It is a vasculitis affecting the large vessels, in particular the aorta and its collateral vessels, especially
- 0 views
- 25 Jan, 2021
- 1 location
Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Introduction Temporal arteritis (TA) is the most common primary vasculitis in the adult population. TA is a systemic multi-organ disease but primarily involves the cranial arteries
- 7 views
- 07 Nov, 2020
- 1 location
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
The purpose of the study is to determine wether a rituximab-based treatment compared to standard therapy (glucocorticoid alone) in patients with microscopic polyangiitis without any bad prognosis marker increases the remission and reduces the relapse free survival rate.
- 0 views
- 23 Jul, 2021
- 1 location